The outbreak of human infection due to the novel swine-origin influenza A (H1N1) virus began in Mexico in March 2009. As of July 6, 2009, more than 94,000 laboratory-confirmed cases were reported in over 100 countries, including 7983 cases in Canada. In this report, we describe the epidemiologic and clinical characteristics of the first cluster of reported cases of human-to-human transmission of the new influenza virus in Canada.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717684 | PMC |
| http://dx.doi.org/10.1503/cmaj.090859 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genomic Evolution and Phylodynamics of the Species (Marburg and Ravn Viruses) to Understand Viral Adaptation and Marburg Virus Disease's Transmission Dynamics.
Pathogens
December 2024
Rwanda Biomedical Center (RBC), Kigali 11KG St 644, Rwanda.
In this review, we investigated the genetic diversity and evolutionary dynamics of the species that includes both Marburg virus (MARV) and Ravn virus (RAVV). Using sequence data from natural reservoir hosts and human cases reported during outbreaks, we conducted comprehensive analyses to explore the genetic variability, constructing haplotype networks at both the genome and gene levels to elucidate the viral dynamics and evolutionary pathways. Our results revealed distinct evolutionary trajectories for MARV and RAVV, with MARV exhibiting higher adaptability across different ecological regions.
View Article and Find Full Text PDFHighly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.
N Engl J Med
December 2024
From the Influenza Division, Centers for Disease Control and Prevention, Atlanta (S.G., K.R., A.C., K.K., C.T.D., M.K.K., S. Ellington, A.M.M., A.B., J.R.B., M.B., M.A.J., M.R.-C., E.B., T.T.S., T.M.U., V.G.D., C.R., S.J.O.); California Department of Public Health, Richmond (E.L.M., S.Z., V.K., D.A.W.); the Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta (S.Z., C.D.); Colorado Department of Public Health and Environment, Denver (C.D., A.K., M.O.); Mid-Michigan District Health Department, Stanton (J.M.); Michigan Department of Health and Human Services, Lansing (S. Eckel); Missouri Department of Health and Senior Services, Jefferson City (J.G., G.T.); Benton-Franklin Health District, Kennewick, WA (S.K.); Washington State Department of Health, Tumwater (A.U.); and Texas Department of State Health Services, Austin (E.R.G., C.A.H.).
Background: Highly pathogenic avian influenza A(H5N1) viruses have caused widespread infections in dairy cows and poultry in the United States, with sporadic human cases. We describe characteristics of human A(H5N1) cases identified from March through October 2024 in the United States.
Methods: We analyzed data from persons with laboratory-confirmed A(H5N1) virus infection using a standardized case-report form linked to laboratory results from the Centers for Disease Control and Prevention influenza A/H5 subtyping kit.
Dynamical modeling of Salmonellosis in humans and dairy cattle with temperature and pH effects.
Res Vet Sci
December 2024
Botswana University of Agriculture and Natural Resources, P/Bag BR 0027, Gaborone, Botswana.
Approximately 20 million cases and 0.15 million human fatalities worldwide each year are caused by Salmonellosis. A mechanistic compartmental model based on ordinary differential equations is proposed to evaluate the effects of temperature and pH on the transmission dynamics of Salmonellosis.
View Article and Find Full Text PDFEstablishing an immune correlate of protection for Nipah virus in nonhuman primates.
NPJ Vaccines
December 2024
Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.
The limited but recurrent outbreaks of the zoonotic Nipah virus (NiV) infection in humans, its high fatality rate, and the potential virus transmission from human to human make NiV a concerning threat with pandemic potential. There are no licensed vaccines to prevent infection and disease. A recombinant Hendra virus soluble G glycoprotein vaccine (HeV-sG-V) candidate was recently tested in a Phase I clinical trial.
View Article and Find Full Text PDFMolecular diagnostics using the QIAstat-Dx syndromic device for covering avian influenza pandemic preparedness.
Heliyon
December 2024
QIAGEN Manchester Ltd, Citylabs 2.0, Hathersage Road, Manchester, M13 0BH, UK.
Introduction: A key factor in influenza pandemic preparedness is the ability to detect zoonotic influenza virus strains as they emerge in humans through spillover events, ideally before human-to-human transmission occurs.
Design: In this study, the utility of the QIAstat-Dx syndromic device for influenza surveillance was evaluated. Bioinformatic analysis was performed on all WHO-recommended influenza Candidate Vaccine Viruses (CVVs), including the common strains recommended for the 2023-2024 influenza vaccine composition in the northern hemisphere, and 16 different H5 highly pathogenic avian influenza virus (HPAIV) and two H9N2 low pathogenic avian influenza virus (LPAIV) strains.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!